Voyager Therapeutics Inc (VYGR)

Voyager Therapeutics Inc (VYGR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $117M; returns 1 day -6.5%, 1 week -8.4%, 1 year -61.8%.

Voyager Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing transformative neurogenetic medicines for severe neurological diseases.

Groups VYGR belongs to

• Biotechnology
• CNS Disorders
• Gene Therapy
• Clinical Stage Biotech
• Neuroscience
• Rare Diseases
• Alzheimer's Disease
• Biopharmaceutical
• Healthcare
• Strategic Partnerships
• Life Sciences

VYGR financial model: income statement, cash flow and balance sheet